Evolution and dynamics of business models in the German biotechnology industry
by Lars Schweizer
International Journal of Biotechnology (IJBT), Vol. 8, No. 3/4, 2006

Abstract: This paper introduces the 'business model' construct in the context of the German biotechnology industry. Four different types of business models are identified: the integrated, the layer player, the orchestrator and the market maker model. First, a brief summary of the current trends in the biotechnology and pharmaceutical industry is presented. After that, we describe four cases of the German biotechnology industry (Axaron BioScience AG, Evotec OAI AG, LION Bioscience AG, Mologen Holding AG). With the help of a comparative case study research approach, we show differences between business models and how biotechnology companies evolve from one model to another. This study shows that companies apply different business models and evolve from one to another.

Online publication date: Wed, 15-Mar-2006

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com